National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
NCCN Mirvetuximab Soravtansine-Preclinical Research Grant Opportunity – Submit by October 26, 2015
Study Proposal Submission-NCCN RMS
ORP Recent News
ORP Affiliate Research Consortium
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
NCCN Shared Resources (Members Only
ORP Disclosure Policy
Call for Abstracts: NCCN General Poster Session
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources

Find a clinical trial >

Profile

As one of the world's premier cancer centers, Memorial Sloan Kettering Cancer Center is committed to exceptional patient care, leading-edge research, and superb educational programs. The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available today as we work to discover more effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan Kettering has an impact on cancer treatment and the biomedical research agenda around the world.

The melding of research with patient care is at the heart of everything we do. At Sloan Kettering Institute, state-of-the-art science research flourishes side-by-side with clinical investigation and treatment at Memorial Hospital, the nation's oldest cancer hospital. We are also one of 39 National Cancer Institute-designated Comprehensive Cancer Centers, affirming our leadership in research, patient care, and education.